Powered by: Motilal Oswal
2026-11-16 10:53:38 am | Source: Accord Fintech
Anuh Pharma rises on inaugurating new manufacturing facility in Maharashtra
Anuh Pharma rises on inaugurating new manufacturing facility in Maharashtra

Anuh Pharma is currently trading at Rs. 83.89, up by 1.37 points or 1.66% from its previous closing of Rs. 82.52 on the BSE.

The scrip opened at Rs. 82.65 and has touched a high and low of Rs. 84.00 and Rs. 82.45 respectively. So far 4864 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 99.50 on 09-Sep-2026 and a 52 week low of Rs. 66.72 on 30-Mar-2026.

Last one week high and low of the scrip stood at Rs. 84.48 and Rs. 80.98 respectively. The current market cap of the company is Rs. 831.86 crore.

The promoters holding in the company stood at 71.80%, while Institutions and Non-Institutions held 0.11% and 28.09% respectively.

Anuh Pharma has inaugurated its new manufacturing facility situated at Tarapur, Boisar, District Palghar, Maharashtra. The new plant is expected to become fully operational within December, 2026, and upon commencement of operations, it will enhance its existing manufacturing capacity by an added 525 Metric Tons per annum (MT/Annum). The existing production capacity is around 2,400 MT per annum, which will increase to around 2,925 MT per annum post-expansion.

Furthermore, the F-10/1 manufacturing facility includes the installation of an added 56 KL of reactor capacity, which will further strengthen its infrastructure and help to meet growing market demands.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here